Key Metrics of Globus Medical
Revenue₹26,412 Cr▲ 22.5% YoYFY 2025-26
EBITDA₹6,800 Cr▲ 89.4% YoY
Net profit₹4,834 Cr▲ 448.3% YoY
Net worth₹41,100 Cr▲ 14.9% YoY
Market cap$10.5BGMED · $78.05
Competitors10identified
Open jobs6
About Globus Medical
Sectors
Company details
- Website
- globusmedical.com
- Founded
- 2012
- Listed
- NYSE: GMED (since 2012)
Operational Areas of Globus Medical
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameGlobus Medical Inc.
TickerGMED
ExchangeNYSE
CountryUnited States
SEC CIK0001237831
Listed since2012
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.globusmedical.com
US market & SEC filings
GMED · NYSE · SEC CIK 0001237831
Last price · 02 Nov 2026
$78.05
−5.86%
Market cap$10.5B
P/E72.9On FY 2023 diluted EPS
Volume1,677,113
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited StatesListed 2012
GMED share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricing
Premium
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit assessment · Commercial vehicles
Rating Methodology – Commercial Vehicles (Sep 2026) · Consolidated accounts · FY 2025-26
Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStable
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Information on file | 33% · missing: Debt obligations and repayment schedule, Capex / investment plans, Lender details, Auditor details, Shareholding pattern, Recent rating review (last 15 months) |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Registered office and contact
Registered officeAudubon
GSTIN—
Email—
Websitehttp://www.globusmedical.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Globus Medical
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Similar companies
R
Regeneron PharmaceuticalsPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
S
Stevanato Group S.p.A.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
A
Amneal Pharmaceuticals, Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
D
Dolby LaboratoriesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
A
American Healthcare REIT Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
S
Sun Pharma Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
I
IncytePharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
L
Lupin Life Sciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
medical technology
Filings
No filings on record yet.